share_log

Spero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Deshpande Milind

SEC ·  May 31 04:35
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more